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The thesis entitled “Uses of Pyrrole Amino Acid based Scaffolds in Peptidomimetics 
and Studies Directed Towards the Total Synthesis of Antascomicin A”, consists of 
three chapters: 
 
            CHAPTER I: Deals with the synthesis and conformational studies of pyrrole amino acid 
based peptidomimetics. 
   
This chapter is divided into two parts: 
 
Part A: Describes the synthesis and conformational studies of linear peptides of pyrrole 
amino acid. 
 
Part B: Describes the synthesis and structural studies of pyrrole amino acid containing 
peptides. 
 
CHAPTER II: Delineates the synthesis and DNA binding properties of pyrrole amino                                                                                   
                          acid containing peptides. 
 
CHAPTER III: Describes the Studies Directed Towards the Total Synthesis of  
                            Antascomicin A. 
 
 
CHAPTER I 
 
Part A 
 
Synthesis and Conformational Studies of Linear Peptides of Pyrrole Amino Acid. 
 
Biological activities of Peptides and proteins depend on their three dimensional 
structures in the free state and when interacting with their receptors/acceptors. The 
search for relationships between structure and activity has been the principal subject for 
designing the selective drugs with no side effects. Initial efforts at finding a connection 
Abstract 
ii 
between structure and activity equated structure with constitution, but it has soon become 
evident that configuration was at least of equal importance. 
Dehydro amino acids (∆Xaa) are found in many naturally occurring peptide 
antibiotics of bacterial origin as well as in some proteins. They have also been used very 
extensively as rigid scaffolds in structural studies of peptides. Synthesis of a novel 
building block based on a pyrrole amino acid (Paa), 5-(aminomethyl)pyrrole-2-
carboxylic acid (1), its application in peptidomimetic studies as a conformationally 
constrained surrogate of the Gly-∆Ala dipeptide residue (2) and the synthesis and 
conformational studies of peptides 3 and 4 prepared from this template (Fig-1). 
                   
 
 
 
 
 
 
 
 
 
One of the most widely used protocols to restrict conformational degrees of freedom 
in small peptides is by covalently stitching the “loose ends” together to fix various torsional 
angles at values characteristic of the target structure. Bridging the terminal carbon of an 
olefinic analogue of a Gly unit and the Cβ atom of an adjacent ∆Ala residue (2) leads to its 
constrained version 1 with fixed ωi, ϕi+1 and probably, ψi+1 torsional angles; 1 was expected 
to nucleate interesting structures in peptides 3 and 4. 
The target peptidomimetics 3 and 4 were prepared from the pyrrole amino acid (Paa) 
which in turn was prepared from pyrrole (Scheme 1) 
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The synthesis of compound 5, i.e. the Boc-protected methyl ester of 1, was started 
from pyrrole 6. The 5-formyl pyrrole-2-carboxylic acid methyl ester was prepared from 6 in 
three steps following known procedures. A Vilsmeir-Haack reaction on pyrrole 6 furnished 
2-formyl pyrrole 7, which was then subjected to Ag2O oxidation followed by treatment with 
CH2N2 to give the 2-carbomethoxy group 9 (Scheme 2). 
 
 
 
 
 
 
 
 
 
 
 
Second Vilsmeir-Haack reaction on pyrrole -2-carboxylic acid methyl ester 9 
formylated 5-position 10 (49%) and 4-position 11 (14%). The compound methyl 5-formyl-
pyrrole-2-carboxylate 10 was reduced using NaBH4 in methanol to give an alcohol 12 in 
92% yield (Scheme 3).  
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was conversion of azide group to primary amine. To achieve this, compound 13 was 
treated with Ph3P in MeOH at room temperature. The resulting primary amine was in-
situ protected with Boc2O to furnish 5 in 60% yield (Scheme 4). 
 
 
 
 
 
 
 
 
 
Compound 5 was subjected to alkaline hydrolysis using LiOH.H2O in THF-
MeOH-H2O (3:1:1) solution to furnish the carboxylic acid 14. The acid 14 was then 
coupled with N-terminal free peptide TFA.H2N-Ala-Leu-Gly-OMe 16 under standard 
solution phase peptide coupling using EDCI and HOBt as coupling agent and DIPEA as 
base in dry CH2Cl2 solution to afford tripeptide Boc-Paa-Ala-Leu-Gly-OMe 3 in 65% 
yield (Scheme 5).  
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The acid Boc-Paa-OH 14 was coupled to TFA.H2N-Leu-Gly-OMe 17 under standard 
peptide coupling conditions desired above to furnish the compound 18 Boc-Paa-Leu-Gly-
OMe in 73% yield. Boc deprotection of 18 using trifluoro acid (TFA) in CH2Cl2 solution  
gave TFA.Paa-Leu-Gly-OMe 19 which was directly used for the peptide coupling reaction in 
the next step. The Boc-Val-OH 20 was treated with TFA.Paa-Leu-Gly-OMe 19 to furnish 
the peptidomimetic 4 in 75% yield (Scheme 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Detailed NMR studies in CDCl3 and DMSO-d6 revealed that pyrrole amino acid 
based peptidomimetic 3 and 4 γ-turn type structure as shown in Figure 1 involving 
intramolecular hydrogen bonding between the pyrrole NH and the carbonyl of the 
previous residues, BocC=O (3) or ValC=O (4) (Fig-2). 
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Figure 2. Schematic representation of the structures of 3 and 4 with the long range rOes seen in their 
ROESY spectra. 
 
 
In conclusion, the rigid scaffold of the pyrrole amino acid described here can serve as 
a conformationally constrained template that may find useful application in developing novel 
peptidomimetics with interesting structures and useful properties.  
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Part B 
 
  Synthesis and Structural Studies of Pyrrole Amino Acid Containing Peptides. 
 
The recognition of β-sheet structures is important for protein-protein interactions. 
Small organic molecules with hydrogen bonding pattern and structure complementary to 
β-sheets are promising for interception of protein-protein interaction, for stopping protein 
aggregation or stabilization or mimicking β-sheet structures. This has led to the design 
and synthesis of a large number of conformationally constrained scaffolds, which help to 
induce β-turns in short peptides, often a prerequisite to β-hairpin nucleation. 
 
Here we describe the design, syntheses and detailed conformational studies of 
three Paa-containing peptides Boc-Paa-Paa-L-Pro-Gly-Ala-Paa-Paa-OMe 2, Boc-Paa-
Paa-D-Pro-Gly-Xaa-Paa-Paa-OMe (3: Xaa = Ala; 4: Xaa = Val) with repeating units of 
Paa dimers at both N- and C-termini (Fig-1).  
 
 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
H2N
N
OH
OH
ωi
φi+1
1 (Paa)
ψi+1
1
2
34
5
6
H
N
N
H
N
O
BocHN
N
H
O
O
NHH
N
O
N
H
H
N
O
N
H
O
H
NMeO2C
2
Abstract 
viii 
 
 
 
 
 
 
 
 
 
It was envisaged that the D-Pro unit with a φ value of +60 ± 20° can induce a 
reverse turn that can be further stabilized by noncovalent interactions facilitated by the 
near planar disposition of the Paa-dimers at both ends with fixed ωi, ϕi+1 and probably, 
ψi+1 torsional angles leading to the formation of hairpin architecture.  
The target peptides 2, 3 and 4 were prepared from Boc-Paa-Paa-OMe 5 which in 
turn was prepared from pyrrole amino acid (Paa) (Scheme 1). 
 
 
 
 
 
 
The peptides 2, 3 and 4 were synthesized from pyrrole amino acid 6 (Paa). The 
required dipeptide Boc-Paa-Paa-OMe 5 was prepared following solution phase peptide 
coupling procedure. The coupling of Boc-Paa-OH 7 with TFA.H2N-Paa-OMe 8, using 
HOBt and EDCI as coupling agents and DIPEA as base in CH2Cl2 gave the dipeptide 
Boc-Paa-Paa-OMe 5 in 85% yield (Scheme 2). 
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The carboxylic acid Boc-Paa-Paa-OH 9 was coupled with TFA.L-Pro-Gly-OMe 
10 and TFA.D-Pro-Gly-OMe 11 using the same conditions desired above to furnish the 
tetrapeptides 12 and 13 in 72% and 76% yields respectively (Scheme 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The other two tripeptides Boc-Ala-Paa-Paa-OMe 16, Boc-Val-Paa-Paa-OMe 18 were 
prepared following the same protocol as described above (Scheme 4). 
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Our next task was to couple the Boc-Paa-Paa-L-Pro-Gly-OMe 12, with the 
tripeptide Boc-Ala-Paa-Paa-OMe 16, to get the target peptide 3. Accordingly, the 
tetrapeptide 12 upon treatment with LiOH.H2O in THF-MeOH-H2O gave Boc-Paa-Paa-
L-Pro-Gly-OH 19, tripeptide Boc-Ala-Paa-Paa-OMe 16 was treated with TFA in DCM 
to give TFA.H2N-Ala-Paa-Paa-OMe 20 which was subsequently coupled with Boc-Paa-
Paa-L-Pro-Gly-OH 19 under standard peptide coupling conditions as discussed above to 
furnish Boc-Paa-L-Pro-Gly-Ala-Paa-Paa-OMe 2 in 65% yield (Scheme 5).  
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The other two peptidomimetics 3 and 4 were synthesized by attaching TFA.H2N-
Ala-Paa-Paa-OMe 20 and TFA.H2N-Val-Paa-Paa-OMe 21 respectively, to the Boc-Paa-
Paa-D-Pro-Gly-OH 22 following the same reaction protocol, as described above for the 
synthesis of 2 (Scheme 6). 
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Detailed NMR studies in CDCl3 and DMSO-d6 and subsequent constrained MD 
simulations revealed that in pyrrole amino acid based peptidomimetic 4, a type-II′ β-turn 
is nucleating around the D-Pro-Gly residues. This leads to subsequent stabilization of β-
hairpin formation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                      (a)                                                                              (b) 
 
 
Figure-2 (a) Schematic representation of the proposed structure of 4 with the long-range ROEs seen in the 
ROESY spectrum. (b) One of the 50 energy-minimized structures of 4 sampled during the 300 ps 
simulated annealing MD studies. 
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In this structure, the Val(5)NH is strongly hydrogen bonded to Paa(2)C=O 
intramolecularly (i + 3 → i) leading to a 10-membered ring structure of type II′ β-turn, 
supported by the φ, ψ angles of D-Pro and Gly (70°, −108° and −106°, 23°, respectively). 
This induces nucleation of three additional hydrogen bonds, Paa(2)pyrroleNH → 
Val(5)CO, Paa(6)PyrroleNH → Paa(1)CO and Paa(1)PyrroleNH → Paa(6)CO, leading 
to the hairpin formation. Comparison of the structures of 3 and 4 makes it evident that 
the replacement of Ala by Val in the 5-position helps compound 4 to adopt the hairpin 
conformation due to the restricted rotation about χ1 of Val, 57° and 181° in Figure 2(b).  
 
In conclusion, the known propensity of D-Pro-Gly unit to induce type II′ β-turn 
coupled with the sheet forming tendency of pyrrole amino acid (Paa) can lead to a very 
well defined β-hairpin conformation in short peptides. 
 
CHAPTER II 
 
Synthesis and DNA Binding Properties of Pyrrole amino acid containing peptides 
 
Many research efforts have been aimed at targeting specific sequences in DNA 
with synthetic ligands with the idea of designing both drugs and molecular probes for 
DNA polymorphism. The minor groove of the double helical DNA is becoming a site of 
great interest for developing new drugs since it is the site of non-covalent high sequence 
specific interactions for a large number of small molecules. Minor groove binders are 
one of the most widely studied class of agents characterized by high level of sequence 
specificity and they are still an interesting class of DNA ligands which demonstrates to 
possess several biological activities. In fact, they exhibit antiprotozoal, antibiotic, 
antiviral properties. Furthermore, some of these have shown antitumor activity and can 
be considered for therapeutical applications. 
It was found that the flexibility of the ligand molecule allowed a substantial 
resetting of the curvature of the ligand, both with respect to the twist along the groove 
and also with respect to matching the bottom of the groove. Pyrrole amino acid (Paa),  
5-(aminomethyl)pyrrole-2-carboxylic acid 1 is a new class of building block that has 
been used in peptidomimetic studies as a structurally restricted surrogate of the Gly-∆Ala 
dipeptide isostere (chapter 1). The flexible methylene spacer between the amino group  
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and the pyrrole ring in 1 is expected to render in peptides derived from it the curvature 
that is necessary to bind in the minor groove of DNA. Herein we describe the synthesis 
and DNA binding properties of three Paa dimer-based polyamides 2-4 (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1. Pyrrole amino acid (Paa) 1 Paa dimmer based polyamides 2-4. 
 
 
The peptide 2 was synthesized from Pyrrole amino acid (paa), the required dipeptide 
Boc-Paa-Paa-OMe 5 was prepared following solution phase peptide coupling procedure. 
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The compound 3 was prepared by coupling Boc-Lys(Boc)-OH 9 with TFA.H2N-Paa-
Paa-OMe 2 using 1-(3-dimethylaminopropyl)-3-ethylcarbodimide hydrochloride (EDCI) 
and 1-hydroxybenzotriazole (HOBt) as coupling agents and DIPEA as base in dry 
CH2Cl2 solution to furnish the peptide 10 in 65% yield. The Boc protection of 10 was 
removed by treating it with trifluroacetic acid (TFA) in CH2Cl2 solution at 0
o
C to give 
compound 3 (Scheme 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The other peptide 4 was synthesized by attaching Boc-Paa-Paa-OH 11 to the H2N-
Lys(Boc)-OMe 13  following the same reaction protocol, as described above for the 
synthesis of 3 (Scheme 3). 
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The binding of these three newly synthesized polyamides containing pyrrole 
amino acid (Paa), with duplex DNA was followed by UV melting, CD spectroscopy, an 
ethidium bromide exclusion experiment followed by fluorescence spectroscopy along 
with a gel electrophoretic mobility assay. Studies showed that all the ligands are able to 
bind duplex DNA. In each of these ligands, the number of building blocks is only two 
and yet they showed considerable binding affinities. It was found earlier that the bis-
pyrrole peptide did not exhibit any detectable binding with duplex DNA. From 
comparative binding studies on bis-, tri-, tetra- and penta-pyrrole peptides of the 
distamycin analogues with DNA it was concluded that the minimum number of pyrrole 
carboxamide units for the onset of DNA binding, in the absence of the N-terminus amide 
is three. In our study, we have observed that ligand 2 is able to bind to ds-DNA with a 
considerable apparent binding affinity (Kapp= 2 × 10
4
 M
−1
) in spite of the fact that this 
ligand contains only two pyrrole-based building blocks. The improvement in the binding 
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affinity may be due to the presence of the methylene spacer between the amino group 
and the pyrrole ring in the ligand, which makes the ligand more flexible to fit in the 
minor groove of the duplex DNA. Ligand 3 binds to duplex DNA with three times higher 
affinity (Kapp= 6 × 10
4
 M
−1
) implying that the extra charge on the ligand improves the 
binding ability of ligand. Ligand 4 with a positive charge placed at both ends of the 
polyamide binds to duplex DNA with twice the affinity of 3 with two positive charges at 
the same end. This result clearly indicates that the spatial distribution of the charge plays 
a crucial role in the binding event of the ligand. In ligand 4 as the two charges are located 
at either end of the polyamide, these charges can neutralize the negative charges of the 
DNA phosphate backbone more efficiently giving increased electrostatic interactions.  
 
In summary we have described the synthesis of polyamides using the monomeric 
building block pyrrole amino acid (Paa), 5-(aminomethyl)pyrrole-2-carboxylic acid. The 
flexible methylene spacer between the amino group and the pyrrole ring in this monomer 
was expected to render the curvature in polyamides derived from it that is necessary to 
bind in the minor groove of DNA. DNA binding studies revealed that polyamides with 
two positive charges bind with affinities of the order of 10
5
. We also observed that the 
polyamide with a positive charge placed at either end of the polyamide binds to the DNA 
duplex with twice the affinity compared to that with two positive charges at the same 
end. These results will help in the more rational design of new minor grove binding 
agents.  
  
 
CHAPTER III 
 
Studies Directed Towards the Total Synthesis of Antascomicin A 
 
FK 506 (tacrolimus) and rapamycin (sirolimus) are potent immunosuppressive agents in 
human clinical organ transplantation. The biological mode of action of these promising 
natural products have been extensively investigated over the past decade. For example, 
FK-506 is known to form an active complex with the cytosolic immunophilin FKBP12, 
which subsequently binds to the secondary proteinous target calcenarium. The latter 
interaction is responsible for potent immunosuppressive activity of FK-506. On the other 
Abstract 
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hand, it has recently been discovered that FKBP is present in the brain at levels 10-40 
times higher than in the immune system, suggesting the possibility of nervous system 
roles for immunophilins. Subsequently, FK-506 has been reported to elicit neurite 
outgrowth and neuroprotective effects in neuronal cultures at pico molar concentrations. 
Although the mechanism of neuronal activity of FKBP has not yet been clarified, it has 
been shown that the neurotrophic properties of FKBP ligands are independent of 
calicineurin-mediated effects. Thus, FKBP ligands are now considered as potential lead 
compounds for the development of drugs for treatment and cure of neurodegenerative 
disorders such as Alzheimer's and Parkinson's diseases. With regard to clinical use, 
efforts have been devoted to the design of neurotrophic FBBP ligands that are non- 
immunosuppressive. 
 
Macrolide antibiotics antascomicin A-E were found in a fermentation broth of a 
strain of Micromonospora, which was isolated from a soil sample collected in China 
(Fig-1). The molecular architecture of antascomicin A was determined by extensive 
NMR studies. Antascomicin A exhibit potent binding affinity to FKBP12 (IC50 2.0 nM) 
and antagonize the immunosuppressive effect of FK506 and rapamycin, but interestingly 
it does not show immunosuppressive activity. 
 
Antascomicin A 1 is an enticing target for the synthetic chemist as it has a 
complex polyketide structure that includes both lactol and lactam functionalities, 11 
stereogenic centers, and a masked 1,2,3-tricarbonyl unit. The wealth of biological 
functions and chemical structures prompted us to initiate a program aimed at the total 
synthesis of antascomicin A.  
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An RCM approach was contemplated to construct the macrocyclic ring of antascomicin A.  
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Scheme 1. Retrosynthetic analysis of antascomicin A (1).
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Retrosynthetic analysis (Scheme 1) reveals that an acyclic precursor like 2 was 
ideally suited to carry out the planned RCM reaction. Triene 2 could be easily assembled 
by coupling the C1-C21 unit 3 with the C22-C34 fragment 4.  
 
Synthesis of C1-C21 unit 
Our synthesis commenced with the mono-benzylation of commercially available 
pentane-1,5-diol 5. Among two free hydroxyl groups of pentane-1,5-diol, one was 
selectively protected using one equivalent each of sodium hydride and benzyl bromide in 
THF to give mono-benzyl protected pentate-1,5-diol 6 in 68% yield. The Swern 
oxidation of 6 provided aldehyde 7, in 92% yield. Asymmetric aldol addition of the 
titanium enolate derived from the N-propanoyl oxazolidinethione 8 to aldehyde 7, gave 
the ‘non-Evans’ syn aldol product 9 as the only isolable diastereomer in 78% yield. 
Reduction of 9 with sodium borohydride in ethanol gave the diol 10 in 90% yield. Diol 10 
was subjected to disilylation by using TBSCl, imidazole and catalytic amount of DMAP 
in DMF to furnish the di-TBS ether 11 and finally debenzylation by hydrogenation gave 
12 in 72% yield from 10 (Scheme 2). 
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Compound 12 was converted to acid 14 in a two-step oxidation protocol. First primary 
alcohol 12 was converted to an aldehyde 13 in 94% yield, using Swern oxidation 
procedures, which, without further purification and characterization was oxidized to acid 
14 with 1.3 equivalents of NaClO2 and 1.3 equivalents of NaH2PO4 in t-BuOH and 2-
methyl-2-butene. Compound 14 was used to carry out N-acylation of the chiral 
oxazolidinone 15, derived from D-Phe, under the mixed anhydride method to furnish 16 
in 85% yield. Diastereoselective alkylation of the Na-enolate of 16 with MeI was 
followed by reductive removal of the chiral auxiliary to give alcohol 18 as the only 
isomer in 46% overall yield (Scheme 3). 
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Swern oxidation of 18 gave an intermediate aldehyde 19, which was reacted with 
the Li-enolate of ethyl acetate to give the β-hydroxy ester 20 as a mixture of isomers in 
85% yield. Saponification of 20 and subsequent coupling with L-pipecolic acid methyl 
ester furnished the amide 22 in 67% overall yield (Scheme 4). 
 
 
 
 
 
 
 
 
 
 
 
 
Oxidation of the β-hydroxy amide 22 with Dess-Martin periodinane (DMP)
 
gave 
an ‘1,2,3-triketo’ intermediate, which was subjected to desilylation resulting in the 
spontaneous formation of the hemiketal 24 in 60% yield. Disilylation of 24 gave a di-
TMS-ether intermediate 25. Brief exposure of this intermediate di-TMS-ether to mild 
acid selectively deprotected the primary hydroxyl group to furnish the TMS-ether of the 
hemiketal 26 in 70% yield. Finally oxidation of 26 gave the aldehyde 27 in 96% yield. 
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Synthesis of the C17-C21 (35) fragment 
 
The synthesis of the C17-C21 (35) fragment started with the pentane-1,5-diol 5. 
One of the hydroxyls of 5 was protected as tert-butyldimethylsilyl ether by using TBSCl 
and NaH in THF at 0°C to room temperature for 3-4 h to afford compound 28 in 72% 
yield. The aldehyde 29 was obtained by the oxidation of the primary hydroxyl group in 
28 by employing the Swern oxidation condition. The aldehyde 29 was reacted with CHI3 
in the presence of anhydrous CrCl2, generated in situ from CrCl3 and LAH, following the 
Takai protocol to introduce an E-vinyl iodide moiety 30, in an overall yield of 73% after 
two steps. Acid-catalyzed desilylation of 30 gave 31 in 81% yield. Tosylation of 31 was 
followed by nucleophilic substitution of the tosylate group by PhSe
−
, generated in-situ by 
sodium borohydride reduction of diphenyl diselenide, giving the phenylselenide 33, in 
78% overall yield, which was then subjected to oxidation-elimination process. Oxidation 
of selenide 33 using mCPBA and subsequent β-elimination of the resulting selenoxide 
furnished the diene 35 in 71% yield (Scheme 6). 
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Coupling of C1-C16 Moiety (27) and C17-C21 (35): 
Coupling of C1-C16 (27) and C17-C21 (35) fragments to build the target C1-C21 
moiety is shown in Scheme 7. A Nozaki-Hiyama-Kishi coupling was employed to carry 
out the coupling, giving the coupled product 36 in 62% yield as a mixture of isomers. 
Finally, Dess-Martin oxidation of 36 furnished dienone 37, the target C1-C21 fragment of 
antascomicin A, in 85% yield. 
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Synthesis of the C22-C34 fragment  
For the synthesis of the C22-C34 fragment 4 of antascomicin A, D-quinic acid was 
chosen as the starting material. Scheme 8 outlines the details of the synthesis. D-(-)-
Quinic acid 38 was transformed into the intermediate 6 in six steps and in 33% overall 
yield following the procedure reported earlier. 
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Silylation of 44 was followed by reduction to furnish the diol 46 in 76% yield. 
Selective acylation of the primary hydroxyl group, silylation of the secondary hydroxyl 
and deprotection of the acetate gave the disilylated intermediate 49 in 78% yield in three 
steps. Finally oxidation of 49 furnished the aldehyde 50 in 95% yield (Scheme 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Horner-Wadsworth-Emmons olefination of 50 with the (1S,2R)-(+)-
norephedrine-derived keto-phosphonate 51 using LiCl-DIPEA provided an α,β-
unsaturated amide intermediate, which was hydrogenated to furnish the N-acylated chiral 
auxiliary 53 (Scheme 10). 
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The two chiral centers in compound 61 were planned to be generated by an Evans 
aldol reaction between 53 and the aldehyde 60, which in turn was prepared from 
commercially available methyl (R)-(-)-3-hydroxy-2-methylpropionate 54. Acid catalyzed 
benzylation of 54, in the presence of O-benzyltrichloroacetamidate and catalytic amount 
of triflic acid in a mixture of cyclohexane and methylene chloride (2:1) at 0
o
C afforded 
the benzyl ether 55 in 87% yield. Treatment of 55 with LiAlH4 in ether at 0
o
C gave the 
alcohol 56 (98% yield).  Compound 56 was then transformed into 60 in four steps, as 
shown below, and in 65% overall yield (Scheme 11). 
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Enolate of 53 was reacted with the aldehyde 60 to furnish the aldol product as a 
single isomer 61. The stereochemistries of the newly generated chiral centers were 
assigned on the basis of earlier reported work. The aldol adduct was then silylated and 
the chiral auxiliary was removed by reduction with lithium triethylborohydride to furnish 
63 in 40% yield in three steps. A two-step protocol was followed to convert the 
hydroxymethyl of 63 to a methyl group – tosylation followed by nucleophilic 
substitution of the tosylate group with hydride – to furnish 65 in 70% yield. 
Debenzylation of 65 by catalytic hydrogenation, oxidation of the resulting primary 
hydroxyl group, one-carbon Wittig olefination and finally an acid-catalyzed desilylation 
step furnished the target fragment 4 in 75% yield (Scheme 12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
63
OTBS
OTBSOH
BnO
OTES
Ph
N
Me
O
O O
OTBS
OTBS
53
1. Bu2BOTf, Et3N, CH2Cl2, −78 
oC
then 60, −78 oC to rt, 12 h
2. TESOTf, 2,6-lutidine, CH2Cl2, 
0 oC, 5 min
3. LiEt3BH, Et2O, 0 
oC, 30 min
40% in three steps
63
1. TsCl, Et3N, DMAP (cat)
CH2Cl2, 0 
oC to rt, 24 h
2. LiEt3BH, THF, −20 to 
0 oC, 5 h
70% in two steps
OTBS
OTBS
BnO
OTES
65
1. H2, Pd-C, EtOAc, rt, 1 h
2. SO3-py, Et3N, DMSO, CH2Cl2, 0 
oC, 1 h
3. (Ph3P-CH3)I, NaNH2, Et2O, 0 
oC, 10 min
4. CSA (cat), MeOH, CH2Cl2, 0 
oC, 5 min
75% in four steps
OTBS
OTBS
OH
4
65
Scheme 12
Abstract 
xxix 
Coupling of C1-C21 Moiety (37) and C22-C34 Moiety (4): 
Having synthesized both the fragments 37 and 4, the stage was know ready to 
couple both the fragments to get compound 2. Initially our target was to deprotect the 
methyl ester of compound 37 to get acid 3. However, all attempts to convert acid 3 from 
the corresponding compound 37 by several methods did not give the corresponding 
product. Our efforts to convert α,β-enone ester 37 to acid 3 by several methods like 
LiOH, Ba(OH)2, TMSOK, TMSI are ended with decomposition of compound 37. Hence 
we were forced to convert methyl ester 37 to an allyl ester by trans esterification method. 
Next allyl ester 66 was successfully converted to acid 3 by using catalytic amount of 
Pd(Ph3P)4 and morpholine in THF gave compound 3 in 60% yield (Scheme 13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound 3 and 4 were successfully coupled by using 1 equivalent of DCC as a 
coupling agent and catalytic amount of DMAP at -20
o
C in CH2Cl2 to furnish the coupled 
product triene 2 in 60% yield. The triene 2 was now ready for the crucial Ring Closing 
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product, protected antascomicin A 67. But the RCM reaction method using 0.1 equivalents 
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desired product 67 and gave rise to an unwanted product (Scheme 14). Our efforts with other 
solvents like benzene and toluene also could not provide the expected product. The synthesis 
suffered a major setback at this point and our achievement became restricted up to the 
synthesis of compound 2 leaving the total synthesis still elusive.  
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